Cryo Cell International (CCEL) EBT Margin (2010 - 2026)

Cryo Cell International (CCEL) has 17 years of EBT Margin data on file, last reported at 0.92% in Q1 2026.

• EBT Margin for Q1 2026 came in at 0.92%, down 578.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 8.95% (down 1688.0% YoY), and the FY2025 annual result was 7.4%, down 1617.0% from the prior year.
• EBT Margin grew to 0.92% in Q1 2026 per CCEL's latest filing, from 59.06% in the prior quarter.
• Over five years, EBT Margin peaked at 18.3% in Q2 2024 and troughed at 203.04% in Q4 2023.
• A 5-year average of 7.03% and a median of 8.34% in 2022 frame the typical range for EBT Margin.
• The sharpest annual moves came in 2023 and 2024: EBT Margin tumbled 21106 bps in 2023, then soared 19254 bps in 2024.
• A 5-year view of EBT Margin shows it stood at 8.02% in 2022, then plunged by 2632 bps to 203.04% in 2023, then surged by 95 bps to 10.5% in 2024, then plunged by 463 bps to 59.06% in 2025, then surged by 102 bps to 0.92% in 2026.
• Business Quant data shows CCEL's EBT Margin at 0.92% in Q1 2026, 59.06% in Q4 2025, and 15.16% in Q3 2025.